Dr. Leslie F. Memsic, MD

Dr. Memsic practices at Innova Surgery Center, LLC in Beverly Hills, California.

Dr. Memsic's NPI, 1821019456, was assigned on July 21, 2006. Dr. Memsic graduated from UC San Diego School of Medicine in 1981. Dr. Memsic holds California license G496380.

Dr. Memsic's primary practice is Innova Surgery Center, LLC, at 436 N Bedford Dr, Beverly Hills, CA 90210 in Los Angeles County. The practice phone is (310) 385-8819.

Dr. Memsic's primary practice is Innova Surgery Center, LLC in Beverly Hills, California. Dr. Memsic is also affiliated with Cedars-Sinai Medical Center. Dmand AI also links Dr. Memsic to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Memsic practices, 6 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Memsic's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Memsic is board certified in surgery by the American Board of Surgery. Dr. Memsic is licensed in California.

Dmand AI lists abdominal hernia repair surgery, breast reconstruction, colon removal, groin hernia surgery and mastectomy among the conditions Dr. Memsic treats.

CMS data shows 1,422 Medicare services from Dr. Memsic across 14 procedure codes in 2024, for 441 Medicare patients. Medicare paid $159,334 for them.

CMS counts 441 Medicare patients who saw Dr. Memsic in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high cholesterol, and 58% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Memsic's median patient age at 67, with 92% women.

In 2024, Dr. Memsic wrote 163 Medicare Part D claims for 58 patients. 95% of them were for generic drugs. CMS names the drug for 93 of them, across 4 drugs with 11 or more claims each, at $1,622 in total drug cost. In 2023, CMS named 80 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Memsic for performance year 2024, reported individually. Dr. Memsic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Memsic as offering telehealth. CMS counts 49 procedures of mastectomy by Dr. Memsic, more than 94% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Memsic. Dr. Memsic's most frequent co-authors are Allan W. Silberman, MD, Stewart Howard Gleischman, MD and Solomon I. Hamburg, MD.

CMS Open Payments shows 7 general payments to Dr. Memsic from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Rti Surgical, Inc paid the most, $92.

Dmand AI lists 4 awards for Dr. Memsic, most recently Top Doctors:LA Area in 2013.

Dr. Memsic graduated from UC San Diego School of Medicine in 1981. Dr. Memsic is a member of ACS.

Dr. Memsic is in network with 4 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.